Improving Gout Care After an ED Visit
NCT06534554 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2026-01-16
Summary
The prevalence of gout has been steadily increasing over several decades and is correlated with the rising burden of obesity, chronic cardiac and renal disease; all conditions overrepresented in the Southeastern U.S. - particularly in African Americans. Through a novel post-emergency department visit intervention, we aim to improve the care patients with gout receive, both during acute exacerbations and long-term. A secondary goal of the project is to concurrently enhance participation of minorities in biomedical research in the Deep South.
Conditions
Interventions
- BEHAVIORAL
-
Patient Navigation
A lay patient navigator working will contact patients seen in the UAB ED via phone within \~72 hours following the ED visit. During this initial phone conversation, the navigators will: 1) conduct a baseline assessment to identify barriers to attending an outpatient visit for gout care and to adhering to gout treatment recommendations and 2) determine the level of support and assistance needed by the patient.
Sponsors & Collaborators
-
University of Alabama at Birmingham
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-06-18
- Primary Completion
- 2027-01-01
- Completion
- 2027-06-01
Countries
- United States
Study Locations
More Related Trials
-
Prevalence of Abnormalities in Ultrasonography of Joint and Tendons in Patients With Gout
NCT05546593 ·Status: RECRUITING
-
Imagery as Biomarker of Gout
NCT05434858 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Virtual Gout Clinic
NCT02790463 ·Status: COMPLETED ·Phase: NA
-
Musculoskeletal Ultrasound in Asymptomatic Hyperuricemia
NCT02502565 ·Status: UNKNOWN
-
A Nurse Led Patient Management Programme to Improve Outcomes in Gout
NCT03345186 ·Status: COMPLETED ·Phase: NA
-
The Diet Gout Trial
NCT03569020 ·Status: COMPLETED ·Phase: NA
-
The Effects of Limb Elevation During Gout Flare Episodes
NCT06207045 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Descriptive Analysis of Dual-energy Computed Tomography Exams of Adult Patients With Gout
NCT05065606 ·Status: UNKNOWN
-
Study on the Efficacy and Safety of Thermotherapy in the Treatment of Refractory Gout
NCT06653686 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
DECT Study in Allopurinol-Treated Gout Patients
NCT02393560 ·Status: COMPLETED
-
Center of Research Translation (CORT) Project 2
NCT02038179 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Arthritis Research UK Gout Treatment Trial - Phase 2
NCT01477346 ·Status: COMPLETED ·Phase: NA
-
Treat-to-target by Email During Urate-lowering Therapy in Gout
NCT04733079 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Assessment of Primary Care Providers' Knowledge and Beliefs Regarding Gout Management
NCT01151709 ·Status: COMPLETED
-
Diagnostic Value of DECT Scan Compared to Diagnostic Needle Aspiration
NCT03038386 ·Status: UNKNOWN ·Phase: NA
-
Italian Observational Study Assessing the Impact of Gout on Patients Disability and Quality of Life
NCT01549210 ·Status: COMPLETED
-
Does Allopurinol Prolong a Treated, Acute Gout Flare?
NCT01988402 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the Correlation Between UltraSonography and Dual-Energy Computed Tomography Assessment of Urate Deposit
NCT03162341 ·Status: COMPLETED ·Phase: NA
-
Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients
NCT05586971 ·Status: COMPLETED ·Phase: PHASE3
-
The Influence of Urate-lowering Therapy on Sperm Quality of Male Gouty Patients:A Prospective Cohort Study
NCT04213534 ·Status: UNKNOWN
-
Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
NCT07145229 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluation of Colchicine and Nonsteroidal Anti-inflammatory Drug Combination Therapy and Renal Function in Gout Patients
NCT05006001 ·Status: UNKNOWN
-
Assessing the Role of the NLRP3 Inflammasome in Intercritical Gout
NCT04125459 ·Status: ACTIVE_NOT_RECRUITING
-
Denosumab In Addition To Intense Urate-Lowering Therapy for Bone Erosions
NCT02903446 ·Status: COMPLETED ·Phase: PHASE2
-
The Remote Monitoring of Gout Study
NCT06822933 ·Status: ENROLLING_BY_INVITATION ·Phase: NA